Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs)
Pharmaceutics · 23.10.2023 · 15 (10) · 2517
DOI: 10.3390/pharmaceutics15102517 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 23.10.2023. Verfasst von Yining Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Drug Development Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Australian National Health and Medical Research Council e-Asia Joint Research Program, USA National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
Abstract (Originalsprache)
Human proton-coupled oligopeptide transporters (PepTs) are important membrane influx transporters that facilitate the cellular uptake of many drugs including ACE inhibitors and antibiotics. PepTs mediate the absorption of di- and tri-peptides from dietary proteins or gastrointestinal secretions, facilitate the reabsorption of peptide-bound amino acids in the kidney, and regulate neuropeptide homeostasis in extracellular fluids. PepT1 and PepT2 have been the most intensively investigated of all PepT isoforms. Modulating the interactions of PepTs and their drug substrates could influence treatment outcomes and adverse effects with certain therapies. In recent studies, topology models and protein structures of PepTs have been developed. The aim of this review was to summarise the current knowledge regarding structure-interaction relationships (SIRs) of PepTs and their substrates as well as the potential applications of this information in therapeutic optimisation and drug development. Such information may provide insights into the efficacy of PepT drug substrates in patients, mechanisms of drug–drug/food interactions and the potential role of PepTs targeting in drug design and development strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Drug Development Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.
- National Glycoengineering Research Center, Shandong University, Qingdao 266237, China.
- Macular Research Group, Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.
- Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA.
- Biomedicine Discovery Institute, Department of Microbiology, Monash University, Melbourne 3800, Australia.
ORCID-Profile: Jingchun Gao, Qi Tony Zhou
Förderung
- NIAID NIH HHS
- Australian National Health and Medical Research Council e-Asia Joint Research Program
- USA National Institute of Allergy and Infectious Diseases of the National Institutes of Health
- Shandong Excellent Young Scientists (Overseas) Fund Program
- Natural Science Foundation of Shandong Province
Zitieren
APA
Luo, Y., Gao, J., Jiang, X., Zhu, L., Zhou, Q. T., Murray, M., Li, J., & Zhou, F. (2023). Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs). Pharmaceutics, 15(10), 2517. https://doi.org/10.3390/pharmaceutics15102517
Vancouver
Luo Y, Gao J, Jiang X, Zhu L, Zhou QT, Murray M, et al. Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs). Pharmaceutics. 2023;15(10):2517. doi:10.3390/pharmaceutics15102517
BibTeX
@article{Luo2023,
author = {Luo, Yining and Gao, Jingchun and Jiang, Xukai and Zhu, Ling and Zhou, Qi Tony and Murray, Michael and Li, Jian and Zhou, Fanfan},
title = {Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs)},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {10},
pages = {2517},
doi = {10.3390/pharmaceutics15102517}
}
EUVIMED